收藏切换
Clinical Observation of Qisheng Gushen Decoction(芪参固肾汤)Combined with Irbesartan in Treatment of Chronic Kidney Disease at Stage 2-3
收藏切换
Wei TIAN, Chenxia JUN, Qiuli WANG, Dongji WANG
Chinese Archives of Traditional Chinese Medicine | 2025, 43(8) : 40 - 43
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2025, 43(8): 40-43
• Target on National Project •
Clinical Observation of Qisheng Gushen Decoction(芪参固肾汤)Combined with Irbesartan in Treatment of Chronic Kidney Disease at Stage 2-3
Full
Wei TIAN, Chenxia JUN, Qiuli WANG, Dongji WANG
Affiliations
  • Lianyungang Traditional Chinese Medicine Hospital,Lianyungang 222000,Jiangsu,China
Published: 2025-08-10 doi: 10.13193/j.issn.1673-7717.2025.08.010
Outline
收藏切换
Objective

To explore the clinical effect of Qisheng Gushen Decoction(芪参固肾汤)combined with irbesartan in the treatment of chronic kidney disease at stage 2~3.

Methods

A total of 110 patients with chronic kidney disease at stage 2~3(admitted from August 2021 to October 2023)were divided into decoction group and western medicine group by random number table method,with 55 cases in each group.The western medicine group received irbesartan and other western medicines,and the decoction group was treated with Qisheng Gushen Decoction on the basis of the western medicine group.In the course of treatment,1 case was shed in the western medicine group and 2 cases were shed in the decoction group.The data of each group was observed as follows:curative effect,integral changes of TCM symptoms(main disease and secondary disease)before and after treatment,changes of renal function indicators,changes of inflammatory factors indicators,changes of intestinal flora,changes of T lymphocyte subsets and other immune function indicators,adverse reactions.

Results

The total effective rate of the decoction group was significantly higher than that of the western medicine group(P<0.05).After treatment,the scores of TCM syndrome(main disease and secondary disease),24-hour urinary protein quantification(24 h-UTP),serum creatinine(SCr),urea nitrogen(BUN),albumin(ALB),estimated glomerular filtration rate(eGFR),interleukin-6(IL-6),interleukin-17(IL-17)and hypersensitive C-reactive protein(hs-CRP),intestinal flora indicators such as Lactobacillus acidophilus,bifidobacterium and Escherichia coli,and immune indicators such as T lymphocyte subsets(CD3+,CD4+,CD8+,CD4+/CD8+)were improved.In the decoction group,these indexes were all better than those in western medicine group(P<0.05).The total adverse reaction rate of the decoction group was lower than that of the western medicine group(P<0.05).

Conclusion

Qisheng Gushen Decoction combined with irbesartan in the treatment of chronic kidney disease at stage 2~3 can regulate the immune function,improve the renal function,immune function and inflammatory response of patients,enhance the therapeutic effect,and reduce adverse reactions,and the treatment is safe and reliable.

chronic kidney disease at stage2-3  /  irbesartan  /  Qisheng Gushen Decoction(芪参固肾汤)  /  kidney function  /  immune function  /  curative effect  /  adverse reaction
田卫, 隽晨霞, 王求利, 王东济. 芪参固肾汤结合厄贝沙坦治疗2~3期慢性肾脏病临床观察. 中华中医药学刊, 2025 , 43 (8) : 40 -43 . DOI: 10.13193/j.issn.1673-7717.2025.08.010
Wei TIAN, Chenxia JUN, Qiuli WANG, Dongji WANG. Clinical Observation of Qisheng Gushen Decoction(芪参固肾汤)Combined with Irbesartan in Treatment of Chronic Kidney Disease at Stage 2-3[J]. Chinese Archives of Traditional Chinese Medicine, 2025 , 43 (8) : 40 -43 . DOI: 10.13193/j.issn.1673-7717.2025.08.010
Year 2025 volume 43 Issue 8
40
17
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2025.08.010
  • Online Date:2026-10-30
  • Published:2025-08-10
Article Data
Affiliations
History
Funding
Affiliations
    Lianyungang Traditional Chinese Medicine Hospital,Lianyungang 222000,Jiangsu,China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2025.08.010
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT